LGALS3 and lung carcinoma: More specifically, most galectin-3 and β-catenin coexpressed lung tissues (n = 106) expressed CD133 (n = 86; Table 2), suggesting that galectin-3/β-catenin were associated with the stem-like properties of lung cancer.